Results 101 to 110 of about 24,009 (265)

Local sensitivity analysis of a supercritical extraction model

The Canadian Journal of Chemical Engineering, Volume 104, Issue 1, Page 312-327, January 2026.
Abstract This study investigates the process of chamomile oil extraction from chamomile flowers. A parameter‐distributed model, consisting of a set of partial differential equations, was used to describe the governing mass transfer phenomena between solid and fluid phases under supercritical conditions using carbon dioxide as the solvent.
Oliwer Sliczniuk, Pekka Oinas
wiley   +1 more source

PENGARUH LANSOPRAZOL DAN OMEPRAZOL TERHADAP AKTIVITAS ENZIM KATALASE HEPAR TIKUS

Berkala Kedokteran, 2016
: Lansoprazole and omeprazole is a Proton Pump Inhibitor class of drugs that are often used for the treatment of peptic ulcers. Lansoprazole and omeprazole have an influence on the various target organs exposed.
Eria Sartika, Eko Suhartono, Agung Biworo   +2 more
doaj   +1 more source

Implications of Long-term Proton Pump Inhibitor Use: Promoting Step-Down Therapy for Management of Gastro-esophageal Reflux Disease in the Outpatient Setting [PDF]

, 2015
Per the International Montreal Consensus, gastro-esophageal reflux disease (GERD) is defined as a condition which develops when the reflux of stomach contents causes troublesome symptoms or complications .
Kapadia, Sonam
core   +1 more source

Potentially inappropriate prescribing in nursing home residents detected with the community pharmacist specific GheOP3S-tool [PDF]

, 2016
Background: The Ghent Older People’s Prescriptions community Pharmacy Screening (GheOP3S-)tool was recently developed to screen for potentially inappropriate prescribing (PIP).
Boussery, Koen, Mattelin, Kristof, Mehuys, Els, PATTYN, EVA, Petrovic, Mirko, Somers, Annemie, Tommelein, Eline, Van Damme, Charlotte   +7 more
core   +1 more source

Insights Into Patient‐Level Exposure to Actionable Pharmacogenomic Medications in Australia Using a New National Pharmacogenomic Guideline

Clinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 89-100, January 2026.
This study assessed the use of 35 pharmacogenomic (PGx) medications listed in the Royal College of Pathologists of Australasia (RCPA) guideline, estimated the potential costs of subsidizing PGx testing in Australia, and predicted related prescribing changes.
Bella D. Ianni, Chin Hang Yiu, Mohammad A. Ali, Christine Y. Lu   +3 more
wiley   +1 more source

Toward a More accurate, Evidence‐Based Classification of CYP Inhibitors: A Critical Appraisal of Current Systems

Clinical Pharmacology &Therapeutics, Volume 119, Issue 1, Page 30-32, January 2026.
In this issue of CPT, Malavé et al. deliver a comprehensive reassessment of CYP2C19 inhibitor classifications through a systematic review of clinical drug–drug interaction (DDI) studies. While their findings bring clarity to specific discrepancies, this commentary explores the origins of such inconsistencies, particularly focusing on methodological ...
Janne T. Backman
wiley   +1 more source

Kosten en effecten van esomeprazol in de behandeling van reflux ziekte [PDF]

, 2002
Doel. Het bepalen van de kosten-effectiviteit van esomeprazol (Nexium(r)) ten opzichte van alle andere in Nederland geregistreerde protonpomp remmers in de behandeling van reflux ziekte.
Al, M.J. (Maiwenn), Buijt, I., Rutten, F.F.H. (Frans)   +2 more
core  

Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study [PDF]

, 2017
journal ...
Ashida, Kiyoshi, Funao, Nobuo, Kawai, Takashi, Matsumoto, Yasushi, MIZOKAMI, Yuji, Nishimura, Akira, Oda, Kazunori, Sugano, Kentaro   +7 more
core   +2 more sources

Acid Suppression in Mild‐Moderate Laryngomalacia Without GERD: A Randomized Controlled Trial

The Laryngoscope, Volume 136, Issue 1, Page 471-478, January 2026.
Infants ≤ 6 months old with mild to moderate laryngomalacia at a tertiary children's hospital were randomized to famotidine and feeding modifications (AST) or feeding modifications alone (no‐AST). Patients randomized to AST (n = 20) and no‐AST (n = 20) had comparable improvement on Laryngomalacia Airway Symptom Score and Infant Gastroesophageal Reflux ...
Amber D. Shaffer, Zainab Balogun, Allison B. J. Tobey, Raymond C. Maguire, Jeffrey P. Simons, Joseph E. Dohar, Jennifer L. Mccoy, Marina V. Rushchak, Reema Padia   +8 more
wiley   +1 more source

Efficacy and safety of vonoprazan versus proton pump inhibitors in the treatment of peptic ulcer disease: a systematic review and network meta-analysis for randomized controlled trails

Frontiers in Nutrition
Background and aimsVonoprazan, a novel acid suppressant, has been employed in the treatment of peptic ulcer disease in recent years. However, the efficacy and safety of vonoprazan versus proton-pump inhibitors remains controversial.
Lidi Tian, Dan Xiang, Feili Yue, Runjie Li, Youping Zhou   +4 more
doaj   +1 more source